Get Opsumit (Macitentan) Approved by Cigna in Pennsylvania: Provider Partnership Guide
Answer Box: Getting Opsumit Covered by Cigna in Pennsylvania
Eligibility: You need a PAH diagnosis confirmed by right heart catheterization, prescribed by a pulmonary hypertension specialist, with documented functional class limitations and pregnancy testing compliance (if applicable).
Fastest Path: Your specialist submits prior authorization through CoverMyMeds or EviCore by Evernorth with complete clinical documentation. Standard review takes 5 business days.
First Step Today: Contact your PAH specialist's office to confirm they have your right heart catheterization results, functional class assessment, and prior therapy documentation ready for submission. If denied, Pennsylvania's external review program overturns roughly 50% of appeals.
Table of Contents
- Set Your Goal: Understanding Approval Requirements
- Visit Prep: Organizing Your Medical History
- Building Your Evidence Kit
- The Medical Necessity Letter Structure
- Supporting Your Doctor During Peer-to-Peer Reviews
- After-Visit Documentation Strategy
- Respectful Persistence: Follow-Up Protocol
- Pennsylvania Appeals Process
- Common Denial Reasons & Solutions
- FAQ
Set Your Goal: Understanding Approval Requirements
Working with your doctor to get Opsumit (macitentan) approved by Cigna requires understanding what the insurer expects to see. Since the REMS program was discontinued in 2025, pregnancy testing requirements remain but the enrollment process has simplified.
Core Approval Criteria
Your partnership with your provider should focus on documenting these essential elements:
Diagnostic Requirements
- Pulmonary arterial hypertension (PAH) diagnosis confirmed by right heart catheterization
- Mean pulmonary artery pressure ≥25 mmHg with pulmonary capillary wedge pressure ≤15 mmHg
- Pulmonary vascular resistance >3 Wood units
Prescriber Qualification
- Prescription from or consultation with a cardiologist, pulmonologist, or PAH specialist
- Ongoing specialist management plan
Clinical Documentation
- WHO functional class II, III, or IV with specific activity limitations
- Documentation of prior PAH therapy attempts or contraindications
- For females of reproductive potential: negative pregnancy test and contraception plan
Note: Cigna typically manages specialty drugs like Opsumit through Express Scripts/Accredo, so your approval may involve multiple entities in the review process.
Visit Prep: Organizing Your Medical History
Before your appointment, create a comprehensive timeline that your doctor can reference when building your case.
Symptom Documentation
Prepare a detailed account of your functional limitations using the WHO classification system:
- Class II: Comfortable at rest, but ordinary activities like climbing stairs cause symptoms
- Class III: Comfortable at rest, but less than ordinary activity produces symptoms
- Class IV: Unable to perform any physical activity without symptoms; may have symptoms at rest
Treatment History Summary
Document every PAH medication you've tried:
- Medication names and dosages
- Start and stop dates
- Reason for discontinuation (lack of efficacy, side effects, contraindications)
- Specific adverse reactions experienced
Current Functional Assessment
Keep a brief daily log for 1-2 weeks before your visit noting:
- Activities that trigger shortness of breath
- How far you can walk without stopping
- Sleep quality and position needed
- Energy levels throughout the day
Building Your Evidence Kit
Your doctor needs comprehensive clinical evidence to support medical necessity. Help them gather:
Laboratory and Imaging Results
- Most recent echocardiogram results
- Right heart catheterization report (essential for Cigna approval)
- Six-minute walk test results if available
- BNP or NT-proBNP levels
- Complete blood count and comprehensive metabolic panel
Published Guidelines Support
Your specialist should reference established treatment guidelines. Key sources include:
- FDA prescribing information for Opsumit
- American College of Cardiology/American Heart Association guidelines
- European Society of Cardiology/European Respiratory Society guidelines
Medication History Documentation
Create a table format your doctor can easily reference:
| Medication | Dates Used | Dosage | Outcome | Reason for Change |
|---|---|---|---|---|
| Sildenafil | Jan-Mar 2024 | 20mg TID | Inadequate response | Disease progression |
| Bosentan | Apr-Jun 2024 | 125mg BID | Side effects | Liver enzyme elevation |
The Medical Necessity Letter Structure
Work with your provider to ensure their prior authorization letter follows this evidence-based structure:
Opening: Clear Problem Statement
"Patient has WHO Group I pulmonary arterial hypertension confirmed by right heart catheterization on [date] showing [specific hemodynamic values]. Current functional class is [II/III/IV] with [specific limitations]."
Clinical Rationale Section
Your doctor should detail:
- Why Opsumit is medically appropriate for your specific PAH phenotype
- How your case meets or exceeds standard treatment guidelines
- Why alternative therapies are unsuitable
Prior Treatment Documentation
- Comprehensive list of previous PAH medications
- Specific reasons each was inadequate or contraindicated
- Timeline showing disease progression despite treatment
Risk Assessment
- Consequences of delayed treatment
- Risk of disease progression without Opsumit
- Patient-specific factors that make this medication essential
Supporting References
Citations to peer-reviewed literature, FDA labeling, and professional guidelines that support the request.
Supporting Your Doctor During Peer-to-Peer Reviews
If Cigna requests a peer-to-peer review, you can help your specialist prepare for this crucial conversation.
Availability Windows
Offer to help coordinate scheduling by:
- Providing your doctor's preferred call times
- Being available if additional patient history is needed during the call
- Ensuring your specialist has all documentation readily accessible
Case Summary Preparation
Help create a concise one-page summary including:
- Your hemodynamic values from right heart catheterization
- Functional class assessment with specific examples
- Previous medication trials with dates and outcomes
- Current symptoms and quality of life impact
From our advocates: "We've seen peer-to-peer reviews go much more smoothly when the specialist has a patient's complete treatment timeline at their fingertips. One pulmonologist told us that having dates, dosages, and specific adverse reactions documented made the difference in a 15-minute call that resulted in same-day approval."
Key Talking Points for Your Doctor
Remind your specialist to emphasize:
- Your diagnosis meets Cigna's specific hemodynamic criteria
- The prescriber is an appropriate PAH specialist
- Previous therapies were tried for adequate duration (≥60 days when possible)
- Functional limitations significantly impact daily activities
After-Visit Documentation Strategy
Maximize the value of each specialist visit by ensuring proper documentation and follow-up.
What to Save
- Clinic visit notes with functional assessment
- Updated medication reconciliation
- Any new test results or imaging reports
- Provider's clinical rationale for Opsumit
Patient Portal Communication
Use your healthcare system's patient portal effectively:
- Request copies of all visit documentation
- Ask for clarification on any prior authorization timeline
- Confirm your specialist has current contact information for urgent communications
Insurance Communication Log
Keep detailed records of all interactions:
- Date and time of calls to Cigna
- Representative names and reference numbers
- Specific information requested or provided
- Follow-up actions required
Respectful Persistence: Follow-Up Protocol
Maintaining appropriate follow-up without overwhelming your healthcare team requires strategy.
Timeline for Updates
- Week 1: Confirm prior authorization was submitted
- Week 2: Check on review status if no response
- Week 3: Inquire about peer-to-peer review options if still pending
- Week 4: Discuss appeal strategy if denied
Escalation Steps
If initial efforts aren't successful:
- Request peer-to-peer review through your specialist
- Ask about expedited review if clinically appropriate
- Prepare for internal appeal with additional documentation
- Consider Pennsylvania's external review process
Communication Style
- Be specific about your needs and timeline concerns
- Acknowledge your healthcare team's workload
- Offer to help with documentation gathering
- Express appreciation for their advocacy efforts
Pennsylvania Appeals Process
Pennsylvania offers one of the most patient-friendly external review processes in the nation, with a 50% success rate in overturning denials.
Internal Appeals First
Before accessing Pennsylvania's external review, you must complete Cigna's internal appeal process and receive a "Final Adverse Benefit Determination" letter.
Pennsylvania External Review Timeline
- Submit within: 4 months of final denial
- Review assignment: Within 1 business day
- Your documentation deadline: 15 days after assignment
- Final decision: Within 45 days of assignment
- Expedited reviews: 72 hours for urgent cases
How to Submit
Use Pennsylvania's online portal at pa.gov/reviewmyclaim or contact the Consumer Services Bureau at 1-877-881-6388.
Required Documentation
- Final denial letter from Cigna
- Your specialist's clinical justification
- Supporting medical records
- Any additional evidence not previously submitted
Common Denial Reasons & Solutions
| Denial Reason | How to Overturn | Key Documentation |
|---|---|---|
| Lack of specialist involvement | Confirm prescriber credentials | Letter from PAH specialist with CV |
| Missing hemodynamic data | Submit catheterization results | Right heart cath report with specific values |
| Inadequate prior therapy trials | Document previous treatments | Medication timeline with dates and outcomes |
| Pregnancy testing non-compliance | Establish testing schedule | Lab results and contraception documentation |
| Off-label use concerns | Provide clinical justification | Guidelines supporting use in your condition |
FAQ
How long does Cigna prior authorization take for Opsumit in Pennsylvania? Standard review is 5 business days. Expedited reviews for urgent cases can be processed within 24-72 hours. You can track status through CoverMyMeds or by calling Cigna directly.
What if Opsumit is non-formulary on my Cigna plan? You can request a formulary exception through your specialist. This requires demonstrating medical necessity and showing why formulary alternatives are inappropriate for your condition.
Can I request an expedited appeal in Pennsylvania? Yes, if your life or health is at serious risk. Expedited external reviews through Pennsylvania's system are decided within 72 hours, and insurers must implement the decision within 24 hours of the ruling.
Does step therapy apply if I've tried medications outside Pennsylvania? Yes, your complete treatment history counts regardless of where you received care. Ensure your current specialist has documentation of all previous PAH therapies, including those from other states or healthcare systems.
What happens if Pennsylvania's external review overturns Cigna's denial? The decision is final and binding. Cigna must immediately provide coverage, including retroactive coverage if you paid out-of-pocket during the appeal process.
For patients and healthcare providers navigating complex insurance approvals, Counterforce Health helps turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with payer requirements. Their platform pulls relevant citations from FDA labeling, peer-reviewed studies, and specialty guidelines while ensuring all procedural requirements are met for different payer workflows.
Sources & Further Reading
- Cigna Prior Authorization Forms
- Pennsylvania External Review Process
- Opsumit Prescribing Information
- CoverMyMeds Cigna Portal
- EviCore by Evernorth
- Accredo Prior Authorization Resources
- Pennsylvania Insurance Department Consumer Services
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and clinical circumstances. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For additional help with Pennsylvania insurance appeals, contact the Pennsylvania Insurance Department Consumer Services Bureau at 1-877-881-6388.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.